AstraZeneca PLC filed a Form 6-K on 16 November 2026 disclosing that the U.S. Food and Drug Administration approved Imfinzi (durvalumab) in combination with enfortumab vedotin as neoadjuvant treatment, followed by Imfinzi monotherapy as adjuvant treatment after radical cystectomy, for adult patients with muscle-invasive …
Invivyd, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 16, 2026, reporting financial results for the three and nine months ended that date.
Duke Robotics Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 16, 2026, disclosing revenue growth alongside a significantly expanded accumulated deficit and a substantial increase in stockholders' equity following new capital raises.
Hornbeck Offshore Services President and CEO Todd M. Hornbeck filed a Form 4 on November 16, 2026, disclosing a open-market purchase of common stock on November 13, 2026.
ExlService Holdings, Inc. Chairman and CEO Rohit Kapoor filed a Form 4 on November 16, 2026, disclosing a sale of 100,000 shares of common stock on November 12, 2026.
Lexeo Therapeutics, Inc. filed a Current Report on Form 8-K on November 16, 2026, announcing financial results for the three and nine months ended September 30, 2026, along with positive interim Phase I/II clinical data for its gene therapy candidate LX2020.
Check Point Software Technologies Ltd officer Nataly Kremer filed a Form 144 notice of proposed sale of 4,341 ordinary shares, submitted on November 16, 2026.
● Apple'sMarket Valueof about $5.18 trillion keeps it the world's most valuable company.
● First-quarter guidance of $11.1 billion beat expectations, but at least 10 firms cut price targets.
● Third-quarterRevenuehit a record $13.4 billion, up 45% from a year earlier.